European Radiology:基于MRI的放射组学分析在乳腺叶状肿瘤与纤维腺瘤鉴别诊断中的价值

2022-03-10 shaosai MedSci原创

乳腺纤维瘤是一种较为罕见的乳腺肿瘤,由上皮和基质成分组成,据报道其发病率不到所有女性乳腺肿瘤的1.0%。

乳腺纤维瘤是一种较为罕见的乳腺肿瘤,由上皮和基质成分组成,据报道其发病率不到所有女性乳腺肿瘤的1.0%。所有的纤维腺瘤都是良性的,而乳腺肿瘤在组织学上可分为良性、交界性或恶性。在治疗纤维腺瘤时,由于复发率高,所有等级的纤维腺瘤都需要进行至少1厘米宽的完全手术切除。

放射线组学分析是一个新兴的转化研究领域,旨在寻找从临床图像中提取的定量信息与其他临床数据之间的关联。肿瘤的异质性是以出血、囊性改变、高细胞密度、坏死和肌样改变等区域为特征的。乳腺MRI的放射组学分析已被应用于区分良性和恶性病变、术前预测前哨淋巴结转移、新辅助化疗的治疗反应、无复发生存以及乳腺癌亚型分析然而很少有研究探讨定量MRI纹理特征对区分乳腺叶状肿瘤和纤维腺瘤的价值。

近日,发表在European Radiology杂志的一项研究开发了一项基于MRI的放射组学机器学习模型,以协助临床术前对乳腺叶状肿瘤及乳腺纤维腺瘤进行准确评估

 

 乳腺叶状肿瘤和纤维腺瘤的磁共振图像。37岁女性病理证实为乳腺叶状肿瘤(a)T2WI、(b)平扫T1WI、(c)DCE-MRI动脉早期、(d)DCE-MRI动脉晚图像25岁女性,病理证实为纤维腺瘤(e) T2WI、(f)平扫T1WI、(g)DCE-MRI动脉早期、(h)DCE-MRI动脉晚图像DCE,动态对比增强;MRI,磁共振成像;T1WI,T1加权成像;T2WI,T2加权成像。

研究表明,基于MRI的放射组学模型可以准确地区分乳腺叶状肿瘤和纤维腺瘤,可以作为临床决策过程中的一个有价值的影像学工具。

 

原文出处

Mitsuteru Tsuchiya,Takayuki Masui,Kazuma Terauchi,et al.MRI-based radiomics analysis for differentiating phyllodes tumors of the breast from fibroadenomas.DOI:10.1007/s00330-021-08510-8.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1954611, encodeId=6044195461197, content=<a href='/topic/show?id=c12ee727447' target=_blank style='color:#2F92EE;'>#纤维腺瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77274, encryptionId=c12ee727447, topicName=纤维腺瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jul 26 04:13:16 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729415, encodeId=3d1e1e294151c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Apr 09 14:13:16 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202201, encodeId=4c6e1202201ce, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=106e6543620, createdName=ms1000000564332448, createdTime=Sun Mar 13 12:28:11 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506990, encodeId=74011506990fb, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Fri Mar 11 23:13:16 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201474, encodeId=436512014e4d5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/ad2f9bec445f4a65920cb05c5a0a8452/e4346fc83e4a4efab3aa50b37eacff5e.jpg, createdBy=bef75416446, createdName=不能空腹吃早餐, createdTime=Thu Mar 10 17:53:40 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201432, encodeId=41aa120143250, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Mar 10 16:18:14 CST 2022, time=2022-03-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1954611, encodeId=6044195461197, content=<a href='/topic/show?id=c12ee727447' target=_blank style='color:#2F92EE;'>#纤维腺瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77274, encryptionId=c12ee727447, topicName=纤维腺瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jul 26 04:13:16 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729415, encodeId=3d1e1e294151c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Apr 09 14:13:16 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202201, encodeId=4c6e1202201ce, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=106e6543620, createdName=ms1000000564332448, createdTime=Sun Mar 13 12:28:11 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506990, encodeId=74011506990fb, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Fri Mar 11 23:13:16 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201474, encodeId=436512014e4d5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/ad2f9bec445f4a65920cb05c5a0a8452/e4346fc83e4a4efab3aa50b37eacff5e.jpg, createdBy=bef75416446, createdName=不能空腹吃早餐, createdTime=Thu Mar 10 17:53:40 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201432, encodeId=41aa120143250, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Mar 10 16:18:14 CST 2022, time=2022-03-10, status=1, ipAttribution=)]
    2022-04-09 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1954611, encodeId=6044195461197, content=<a href='/topic/show?id=c12ee727447' target=_blank style='color:#2F92EE;'>#纤维腺瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77274, encryptionId=c12ee727447, topicName=纤维腺瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jul 26 04:13:16 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729415, encodeId=3d1e1e294151c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Apr 09 14:13:16 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202201, encodeId=4c6e1202201ce, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=106e6543620, createdName=ms1000000564332448, createdTime=Sun Mar 13 12:28:11 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506990, encodeId=74011506990fb, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Fri Mar 11 23:13:16 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201474, encodeId=436512014e4d5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/ad2f9bec445f4a65920cb05c5a0a8452/e4346fc83e4a4efab3aa50b37eacff5e.jpg, createdBy=bef75416446, createdName=不能空腹吃早餐, createdTime=Thu Mar 10 17:53:40 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201432, encodeId=41aa120143250, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Mar 10 16:18:14 CST 2022, time=2022-03-10, status=1, ipAttribution=)]
    2022-03-13 ms1000000564332448

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1954611, encodeId=6044195461197, content=<a href='/topic/show?id=c12ee727447' target=_blank style='color:#2F92EE;'>#纤维腺瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77274, encryptionId=c12ee727447, topicName=纤维腺瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jul 26 04:13:16 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729415, encodeId=3d1e1e294151c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Apr 09 14:13:16 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202201, encodeId=4c6e1202201ce, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=106e6543620, createdName=ms1000000564332448, createdTime=Sun Mar 13 12:28:11 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506990, encodeId=74011506990fb, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Fri Mar 11 23:13:16 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201474, encodeId=436512014e4d5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/ad2f9bec445f4a65920cb05c5a0a8452/e4346fc83e4a4efab3aa50b37eacff5e.jpg, createdBy=bef75416446, createdName=不能空腹吃早餐, createdTime=Thu Mar 10 17:53:40 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201432, encodeId=41aa120143250, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Mar 10 16:18:14 CST 2022, time=2022-03-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1954611, encodeId=6044195461197, content=<a href='/topic/show?id=c12ee727447' target=_blank style='color:#2F92EE;'>#纤维腺瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77274, encryptionId=c12ee727447, topicName=纤维腺瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jul 26 04:13:16 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729415, encodeId=3d1e1e294151c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Apr 09 14:13:16 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202201, encodeId=4c6e1202201ce, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=106e6543620, createdName=ms1000000564332448, createdTime=Sun Mar 13 12:28:11 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506990, encodeId=74011506990fb, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Fri Mar 11 23:13:16 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201474, encodeId=436512014e4d5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/ad2f9bec445f4a65920cb05c5a0a8452/e4346fc83e4a4efab3aa50b37eacff5e.jpg, createdBy=bef75416446, createdName=不能空腹吃早餐, createdTime=Thu Mar 10 17:53:40 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201432, encodeId=41aa120143250, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Mar 10 16:18:14 CST 2022, time=2022-03-10, status=1, ipAttribution=)]
    2022-03-10 不能空腹吃早餐

    #学习#学习一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1954611, encodeId=6044195461197, content=<a href='/topic/show?id=c12ee727447' target=_blank style='color:#2F92EE;'>#纤维腺瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77274, encryptionId=c12ee727447, topicName=纤维腺瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jul 26 04:13:16 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729415, encodeId=3d1e1e294151c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Apr 09 14:13:16 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202201, encodeId=4c6e1202201ce, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=106e6543620, createdName=ms1000000564332448, createdTime=Sun Mar 13 12:28:11 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506990, encodeId=74011506990fb, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Fri Mar 11 23:13:16 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201474, encodeId=436512014e4d5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/ad2f9bec445f4a65920cb05c5a0a8452/e4346fc83e4a4efab3aa50b37eacff5e.jpg, createdBy=bef75416446, createdName=不能空腹吃早餐, createdTime=Thu Mar 10 17:53:40 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201432, encodeId=41aa120143250, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Mar 10 16:18:14 CST 2022, time=2022-03-10, status=1, ipAttribution=)]
    2022-03-10 yangchou

    好文章,谢谢分享。

    0

相关资讯

2016乳腺纤维腺瘤诊治专家共识发布

乳腺纤维腺瘤是常见的乳腺良性疾病,自然病程较长,确诊依据病理学检查,处理方法包括随访观察和外科干预。目前国内外对纤维腺瘤的处理方法选择标准不一,缺乏统一的诊疗规范。中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学组组织国内部分专家编写《乳腺纤维腺瘤诊治专家共识》,期望能对乳腺纤维腺瘤的诊断与治疗起到一定的指导和参考作用。全文获取:下载地址:指南下载 (需要扣积分2分, 梅斯医

超声引导微波(射频)消融治疗乳腺纤维腺瘤专家共识

目前,主要的微创手术方式包括微创旋切和能量消融治疗。真空辅助乳腺微创旋切系统由旋切刀和真空抽吸泵两部分装置组成,旋切刀在真空抽吸泵的辅助作用下对病灶组织进行切割,切取组织进行活检或者重复切割直至病灶完全切除。由于该治疗切口小,因而被视为美容手术用于乳腺良性肿瘤的治疗。但是,其仍然存在一些突出的问题,主要包括内部创伤大、肿瘤残留和术后血肿等。能量消融治疗通常可以分为冷冻消融、热消融和不可逆性电穿孔3

Nat Genet:女性常见乳腺肿瘤的遗传基因MED12

乳腺纤维腺瘤(Fibroadenomas),发生于乳腺小叶内纤维组织和腺上皮的混合性瘤,是乳房良性肿瘤中最常见的一种。乳腺纤维腺瘤可发生于青春期后的任何年龄的女性,但以18~25岁的青年女性多见。最近,新加坡国立癌症中心、杜克新加坡国立医学研究所和新加坡总医院的科学家组成的一个多学科小组,对于理解乳腺纤维腺瘤的分子基础,作出了开创性的突破。由Teh Bin Tean、Patrick Tan、Tan